G1 Therapeutics Inc Stock Analysis
Technical stock analysis for Tue 11'th Dec 2018
G1 Therapeutics Inc gained 0.48% in the last trading day, rising from $33.00 to $33.16 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has been going up and down for this period, and there has been a -16.95% loss for the last 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 80 803 more shares were traded than the day before. In total, 403 568 shares bought and sold for approximately $13.38 million.
G1 Therapeutics Inc lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -40.85% during the next 3 months and, with 90% probability hold a price between $13.26 and $22.78 at the end of this period.
A buy signal was issued from a pivot bottom point on Friday December 07, 2018, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. G1 Therapeutics Inc holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $34.53 and $39.03. A break-up above any of these levels will issue buy signals.
Relative Strength Index (RSI)
RSI14 is 38 and the stock is currently not being overbought or oversold
Support & Resistance
G1 Therapeutics Inc finds support from accumulated volume at $33.00.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.13 between high and low, or 3.47%. For the last week, the stock has had a daily average volatility of 10.50%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
G1 Therapeutics Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
|GTHX $33.16 $0.16(0.48%)|
GTHX is up $0.16 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for GTHX based on the 1-3 month system that more than doubles the S&P 500.
Click here – the GTHX analysis is free »